Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Imaging during radiation therapy captures abrupt and dramatic changes.

Kong FM, Wong KK, Ritter T.

J Thorac Oncol. 2012 Nov;7(11):1736-7. doi: 10.1097/JTO.0b013e31826bb8cc. No abstract available.

2.

Dynamic threshold for radiation target volume by PET/CT.

Wong CY, Mahajan P, Yan D.

J Nucl Med. 2007 May;48(5):849; author reply 847. No abstract available.

3.

Results of a phase I study to dose escalate using intensity modulated radiotherapy guided by combined PET/CT imaging with induction chemotherapy for patients with non-small cell lung cancer.

Holloway CL, Robinson D, Murray B, Amanie J, Butts C, Smylie M, Chu K, McEwan AJ, Halperin R, Roa WH.

Radiother Oncol. 2004 Dec;73(3):285-7.

PMID:
15588872
4.

Image-guided radiation therapy for non-small cell lung cancer.

Chang JY, Dong L, Liu H, Starkschall G, Balter P, Mohan R, Liao Z, Cox JD, Komaki R.

J Thorac Oncol. 2008 Feb;3(2):177-86. doi: 10.1097/JTO.0b013e3181622bdd. Review.

5.

Stage migration in planning PET/CT scans in patients due to receive radiotherapy for non-small-cell lung cancer.

Geiger GA, Kim MB, Xanthopoulos EP, Pryma DA, Grover S, Plastaras JP, Langer CJ, Simone CB 2nd, Rengan R.

Clin Lung Cancer. 2014 Jan;15(1):79-85. doi: 10.1016/j.cllc.2013.08.004. Epub 2013 Oct 8.

PMID:
24238934
6.

18F-FDG PET in planning radiation treatment of non-small cell lung cancer: where exactly is the tumor?

Dahele MR, Ung YC.

J Nucl Med. 2007 Aug;48(8):1402; author reply 1403. No abstract available.

7.

[Target volume margins for lung cancer: internal target volume/clinical target volume].

Jouin A, Pourel N.

Cancer Radiother. 2013 Oct;17(5-6):428-33. doi: 10.1016/j.canrad.2013.05.008. Epub 2013 Aug 27. Review. French.

PMID:
23988437
8.

PET and PET-CT in radiation treatment planning for lung cancer.

Aristei C, Falcinelli L, Palumbo B, Tarducci R.

Expert Rev Anticancer Ther. 2010 Apr;10(4):571-84. doi: 10.1586/era.09.195. Review.

PMID:
20397922
9.

[Impact of computed tomography (CT) and 18F-deoxyglucose-coincidence detection emission tomography (FDG-CDET) image fusion for optimisation of conformal radiotherapy in non-small-cell lung cancers].

Deniaud-Alexandre E, Touboul E, Lerouge D, Grahek D, Foulquier JN, Petegnief Y, Grès B, El Balaa H, Keraudy K, Kerrou K, Montravers F, Milleron B, Lebeau B, Talbot JN.

Cancer Radiother. 2005 Sep;9(5):304-15. Epub 2005 Aug 8. French.

PMID:
16087377
10.

The impact of PET and PET/CT on treatment planning and prognosis of patients with NSCLC treated with radiation therapy.

Nawara C, Rendl G, Wurstbauer K, Lackner B, Rettenbacher L, Datz L, Studnicka M, Sedlmayer F, Pirich C.

Q J Nucl Med Mol Imaging. 2012 Apr;56(2):191-201. Epub 2012 Mar 9.

PMID:
22402822
11.

Guidelines for the role of FDG-PET/CT in lung cancer management.

Al-Jahdali H, Khan AN, Loutfi S, Al-Harbi AS.

J Infect Public Health. 2012 Dec;5 Suppl 1:S35-40. doi: 10.1016/j.jiph.2012.09.003. Epub 2012 Nov 6.

12.
13.

[Contribution of PET/CT for staging and prognosis of non-small cell lung carcinoma. Assessment of the pathological response].

Kerrou K.

Rev Pneumol Clin. 2009 Feb;65(1):49-55. doi: 10.1016/j.pneumo.2008.08.004. Epub 2009 Feb 20. French. No abstract available.

PMID:
19306785
14.

Differential (18)F-FDG and (18)F-FLT Uptake on Serial PET/CT Imaging Before and During Definitive Chemoradiation for Non-Small Cell Lung Cancer.

Everitt SJ, Ball DL, Hicks RJ, Callahan J, Plumridge N, Collins M, Herschtal A, Binns D, Kron T, Schneider M, MacManus M.

J Nucl Med. 2014 Jul;55(7):1069-74. doi: 10.2967/jnumed.113.131631. Epub 2014 May 15.

15.

[Application of standardized uptake value for FDG PET-CT in predicting radiation pneumonitis].

Zhang Y, Yu YH, Yu JM, He W, Fu Z, Guo SF, Liu XJ, Cong CS.

Zhonghua Zhong Liu Za Zhi. 2009 Aug;31(8):622-5. Chinese.

PMID:
20021952
16.

Correlating metabolic and anatomic responses of primary lung cancers to radiotherapy by combined F-18 FDG PET-CT imaging.

Wong CY, Schmidt J, Bong JS, Chundru S, Kestin L, Yan D, Grills I, Gaskill M, Cheng V, Martinez AA, Fink-Bennett D.

Radiat Oncol. 2007 May 23;2:18.

17.

Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results.

Nomori H, Mori T, Ikeda K, Kawanaka K, Shiraishi S, Katahira K, Yamashita Y.

J Thorac Cardiovasc Surg. 2008 Apr;135(4):816-22. doi: 10.1016/j.jtcvs.2007.10.035.

18.

Coregistered whole body magnetic resonance imaging-positron emission tomography (MRI-PET) versus PET-computed tomography plus brain MRI in staging resectable lung cancer.

Parry PV, Engh JA.

Neurosurgery. 2013 Dec;73(6):N11-3. doi: 10.1227/01.neu.0000438331.72566.2e. No abstract available.

PMID:
24257336
19.

Impact of FDG PET/CT on delineation of the gross tumor volume for radiation planning in non-small-cell lung cancer.

Spratt DE, Diaz R, McElmurray J, Csiki I, Duggan D, Lu B, Delbeke D.

Clin Nucl Med. 2010 Apr;35(4):237-43. doi: 10.1097/RLU.0b013e3181d18eb0.

PMID:
20305410
20.

PET/CT imaging for target volume delineation in curative intent radiotherapy of non-small cell lung cancer: IAEA consensus report 2014.

Konert T, Vogel W, MacManus MP, Nestle U, Belderbos J, Grégoire V, Thorwarth D, Fidarova E, Paez D, Chiti A, Hanna GG.

Radiother Oncol. 2015 Jul;116(1):27-34. doi: 10.1016/j.radonc.2015.03.014. Epub 2015 Apr 10. Review.

Supplemental Content

Support Center